RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,994 | -90.2% | 12,998 | -92.0% | 0.00% | – |
| Q2 2023 | $399,374 | -11.6% | 162,347 | -18.8% | 0.00% | – |
| Q1 2023 | $451,602 | -50.6% | 199,824 | -23.6% | 0.00% | – |
| Q4 2022 | $913,365 | -65.4% | 261,709 | +266.8% | 0.00% | -100.0% |
| Q3 2022 | $2,641,000 | -24.5% | 71,347 | -61.3% | 0.00% | 0.0% |
| Q2 2022 | $3,498,000 | +342.2% | 184,174 | +528.8% | 0.00% | – |
| Q1 2022 | $791,000 | -58.3% | 29,291 | -65.2% | 0.00% | – |
| Q4 2021 | $1,899,000 | -15.9% | 84,288 | -2.1% | 0.00% | – |
| Q3 2021 | $2,257,000 | +252.1% | 86,082 | +329.4% | 0.00% | – |
| Q2 2021 | $641,000 | -21.8% | 20,045 | -13.9% | 0.00% | – |
| Q1 2021 | $820,000 | +81.4% | 23,284 | +65.3% | 0.00% | – |
| Q4 2020 | $452,000 | -87.5% | 14,085 | -86.7% | 0.00% | -100.0% |
| Q1 2020 | $3,624,000 | +1617.5% | 106,245 | +1862.8% | 0.00% | – |
| Q4 2019 | $211,000 | – | 5,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |